Filings
Finds words inside filing documents. Searching Gossamer Bio, Inc.'s filings · 54 documents indexed.
16 documents · 22 matches
-
GOSS Gossamer Bio, Inc. 10-K 2026-03-17
Item 1A. Risk Factors.
tariffs, potential changes or pauses to such tariffs, tariff levels, and whether further additional tariffs or other retaliatory actions may be imposed5 matches in this document -
GOSS Gossamer Bio, Inc. 10-Q 2025-05-15
Item 1A. Risk Factors
tariffs, export controls, and other policies. The President of the United States has directed agencies to reassess key aspects of U.S. trade3 matches in this document -
GOSS Gossamer Bio, Inc. 10-Q 2026-11-10
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
private placement, the potential impact of U.S. trade policy, including tariffs, and future results of seralutinib, are forward-looking statements.1 match in this document -
GOSS Gossamer Bio, Inc. 8-K 2026-09-11
tariffs and trade policies may adversely affect the Company’s business and financial condition and the broader economy and biotechnology1 match in this document -
GOSS Gossamer Bio, Inc. 8-K 2026-09-11
Item 8.01. Other Events.
tariffs and trade policies may adversely affect the Company’s business and financial condition and the broader economy and biotechnology1 match in this document -
GOSS Gossamer Bio, Inc. 8-K 2026-09-09
tariffs and trade policies may adversely affect the Company’s business and financial condition and the broader economy and biotechnology1 match in this document -
GOSS Gossamer Bio, Inc. 8-K 2026-09-09
Item 8.01. Other Events.
tariffs and trade policies may adversely affect the Company’s business and financial condition and the broader economy and biotechnology1 match in this document -
GOSS Gossamer Bio, Inc. 8-K 2026-08-13
tariffs and trade policies may adversely affect the Company’s business and financial condition and the broader economy and biotechnology1 match in this document -
GOSS Gossamer Bio, Inc. 10-Q 2026-08-13
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
stock split, the potential impact of U.S. trade policy, including tariffs, and future results of seralutinib, are forward-looking statements.1 match in this document -
GOSS Gossamer Bio, Inc. 8-K 2026-07-27
tariffs and trade policies may adversely affect the Company’s business and financial condition and the broader economy and biotechnology1 match in this document -
GOSS Gossamer Bio, Inc. 8-K 2026-05-18
Item 8.01. Other Events.
tariffs and trade policies may adversely affect the Company’s business and financial condition and the broader economy and biotechnology1 match in this document -
GOSS Gossamer Bio, Inc. 8-K 2026-05-18
tariffs and trade policies may adversely affect the Company's business and financial condition and the broader economy and biotechnology1 match in this document -
GOSS Gossamer Bio, Inc. 8-K 2026-05-18
tariffs and trade policies may adversely affect the Company’s business and financial condition and the broader economy and biotechnology1 match in this document -
GOSS Gossamer Bio, Inc. 10-Q 2026-05-15
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariffs, and future results of seralutinib, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other1 match in this document -
GOSS Gossamer Bio, Inc. 10-Q 2025-11-05
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariffs, and future results of seralutinib, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other1 match in this document -
GOSS Gossamer Bio, Inc. 10-Q 2025-08-05
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariffs, and future results of seralutinib, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other1 match in this document
Page 1 of 1 · 16 documents